Keyword Connections

cost-effectiveness analysis

Journals

15

1 PloS one

2 annales pharmaceutiques francaises

3 BMJ open

4 clinical therapeutics

5 Antimicrobial resistance and infection control

6 health policy (amsterdam, netherlands)

7 international journal of technology assessment in health care

8 Public health

9 international journal of health policy and management

10 Health policy and planning

11 georgian medical news

12 psychiatric services (washington, dc)

13 mdm policy & practice

14 Cancer medicine

15 the indian journal of tuberculosis

Research Groups

0

No Research Group Connected

Bibliographies

61

1 The effect of religion on the perception of health states among adults in the United Arab Emirates: a qualitative study.

2 Does competition improve financial stability of the banking sector in ASEAN countries? An empirical analysis.

3 Commentary. In Praise of Studies That Use More Than One Generic Preference-Based Measure.

4 A cost-effectiveness analysis of lowering residential radon levels in Sweden-Results from a modelling study.

5 Cost effectiveness of decentralised care model for managing MDR-TB in India.

6 Cost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.

7 Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).

8 [PROBLEM OF ENSURING THE RIGHT TO MEDICAL CARE OF A DETAINEE (DETAINED IN CUSTODY) WITHIN CRIMINAL PROCEEDINGS: EXPERIENCE OF UKRAINE AND FOREIGN COUNTRIES].

9 Reflecting the health opportunity costs of funding decisions within value frameworks: Initial estimates and the need for further research.

10 The cost-effectiveness of limiting federal housing vouchers to use in low-poverty neighborhoods in the United States.

11 Statistical Properties of Parasite Density Estimators in Malaria

12 Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey

13 physical activity reduced hypertension in the elderly and cost-effective

14 different approaches to modelling the cost-effectiveness of schistosomiasis control

15 definición de prioridades para las intervenciones de salud en el sistema de protección social en salud de méxico priority setting for health interventions in mexico's system of social protection in health

16 cost-effectiveness of a family planning voucher program in rural pakistan

17 economic evaluation enhances public health decision making

18 impact assessment and cost-effectiveness of m-health application used by community health workers for maternal, newborn and child health care services in rural uttar pradesh, india: a study protocol

19 Participatory learning and action cycles with women s groups to prevent neonatal death in low-resource settings: A multi-country comparison of cost-effectiveness and affordability.

20 Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis.

21 Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

22 Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

23 Screening and Intervention for Suicide Prevention: A Cost-Effectiveness Analysis of the ED-SAFE Interventions.

24 Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.

25 Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia.

26 Cost-Effectiveness Analysis of Psoriasis Treatment Modalities in Malaysia.

27 Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trial.

28 The lifetime costs of pediatric abusive head trauma and a cost-effectiveness analysis of the Period of Purple crying program in British Columbia, Canada.

29 Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbations: a cost-effectiveness analysis.

30 Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective.

31 A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients.

32 The distributional impact of taxing sugar-sweetened beverages: findings from an extended cost-effectiveness analysis in South Africa.

33 Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK.

34 Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial.

35 Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

36 A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan.

37 Structured Pharmacist Review of Medication in Older Hospitalised Patients: A Cost-Effectiveness Analysis.

38 Cost-Effectiveness Analysis for Influenza Vaccination Coverage and Timing in Tropical and Subtropical Climate Settings: A Modeling Study.

39 Gonadotrophins or clomiphene citrate in couples with unexplained infertility undergoing intrauterine insemination: a cost-effectiveness analysis.

40 A Cost-Effectiveness Analysis of Blended Versus Face-to-Face Delivery of Evidence-Based Medicine to Medical Students.

41 Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis.

42 Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

43 Primary surgical management of anterior pelvic organ prolapse: a systematic review, network meta-analysis and cost-effectiveness analysis.

44 Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong.

45 Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.

46 Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.

47 Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin Regimen for Patients Infected with Chronic Hepatitis C Virus Genotype 1 in Malaysia

48 Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

49 Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis

50 generalized cost-effectiveness analysis for national-level priority-setting in the health sector

51 cost-effectiveness analysis of combined use of oral antihypertensive outpatient hypertension in regional general hospital tugurejo semarang period 2007

52 an alternative vaccination approach for the prevention of highly pathogenic avian influenza subtype h5n1 in the red river delta, vietnam —a geospatial-based cost-effectiveness analysis

53 challenges of using cost-effectiveness analysis in rationalizing health care public spending

54 when and how often to screen for cervical cancer in three low- and middle-income countries: a cost-effectiveness analysis

55 cost-effectiveness analysis of rotavirus vaccination among libyan children using a simple economic model

56 endoscopic stenting versus surgical bypass in advanced malignant distal bile duct obstruction: cost-effectiveness analysis

57 the application of software "farmekspert service" for cost-effectiveness analysis

58 análisis de la relación coste-efectividad de la acarbosa en el tratamiento de pacientes con intolerancia a la glucosa cost-effectiveness analysis of acarbose in the treatment of patients with impaired glucose tolerance

59 difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix

60 Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

61 Photobiomodulation and myofascial temporomandibular disorder: Systematic review and meta-analysis followed by cost-effectiveness analysis.